Onkar Dha

Onkar Dha has an extensive background in clinical biospecimen management and operations, currently serving in this role at Nektar Therapeutics since May 2020. Prior experience includes working as a Biospecimen Operations Specialist at the Parker Institute for Cancer Immunotherapy from January 2018 to January 2019, and holding various positions at Clovis Oncology, including Specialist II in TM Operations from September 2013 to October 2018. Onkar Dha began a career in the industry at Celgene as Specialist I in TD Operations from January 2013 to September 2013 and previously worked as a Clinical Trial Coordinator at Veracyte, Inc. from December 2008 to July 2012.